Citizens Financial Group Inc Abbott Laboratories Transaction History

Citizens Financial Group Inc

  • $4.91 Billion
  • Q3 2024

A detailed history of Citizens Financial Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Citizens Financial Group Inc holds 118,708 shares of ABT stock, worth $13.6 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
118,708
Previous 124,225 4.44%
Holding current value
$13.6 Million
Previous $12.9 Million 4.84%
% of portfolio
0.28%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$100.07 - $118.13 $552,086 - $651,723
-5,517 Reduced 4.44%
118,708 $13.5 Million
Q2 2024

Aug 09, 2024
BUY
$100.73 - $112.44 $8.89 Million - $9.93 Million
88,275 Added 245.55%
124,225 $12.9 Million
Q1 2024

May 17, 2024
BUY
$109.52 - $120.96 $838,923 - $926,553
7,660 Added 27.08%
35,950 $4.09 Million
Q4 2023

Feb 02, 2024
BUY
$90.19 - $110.4 $406,486 - $497,572
4,507 Added 18.95%
28,290 $3.11 Million
Q3 2023

Nov 13, 2023
SELL
$95.53 - $114.62 $84,926 - $101,897
-889 Reduced 3.6%
23,783 $2.3 Million
Q2 2023

Aug 04, 2023
SELL
$100.78 - $112.29 $2,519 - $2,807
-25 Reduced 0.1%
24,672 $2.69 Million
Q1 2023

May 10, 2023
BUY
$96.86 - $114.01 $2,808 - $3,306
29 Added 0.12%
24,697 $2.5 Million
Q4 2022

Feb 09, 2023
SELL
$95.06 - $111.52 $15,779 - $18,512
-166 Reduced 0.67%
24,668 $2.71 Million
Q3 2022

Nov 10, 2022
SELL
$96.76 - $112.03 $12,772 - $14,787
-132 Reduced 0.53%
24,834 $2.4 Million
Q2 2022

Aug 05, 2022
BUY
$102.07 - $123.37 $81,247 - $98,202
796 Added 3.29%
24,966 $2.71 Million
Q1 2022

May 12, 2022
SELL
$114.02 - $139.04 $51,194 - $62,428
-449 Reduced 1.82%
24,170 $2.86 Million
Q4 2021

Feb 10, 2022
SELL
$115.53 - $141.46 $8,433 - $10,326
-73 Reduced 0.3%
24,619 $3.47 Million
Q3 2021

Nov 05, 2021
SELL
$116.66 - $129.06 $1.64 Million - $1.81 Million
-14,046 Reduced 36.26%
24,692 $2.92 Million
Q2 2021

Aug 04, 2021
BUY
$105.79 - $124.53 $1.69 Million - $1.99 Million
15,962 Added 70.08%
38,738 $4.49 Million
Q1 2021

May 14, 2021
BUY
$108.84 - $128.23 $79,779 - $93,992
733 Added 3.33%
22,776 $2.73 Million
Q4 2020

Feb 11, 2021
SELL
$105.0 - $114.42 $181,650 - $197,946
-1,730 Reduced 7.28%
22,043 $2.41 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $1.58 Million - $1.92 Million
-17,285 Reduced 42.1%
23,773 $2.58 Million
Q2 2020

Aug 12, 2020
BUY
$76.57 - $98.0 $11,562 - $14,798
151 Added 0.37%
41,058 $3.75 Million
Q1 2020

May 08, 2020
BUY
$62.82 - $91.86 $1.07 Million - $1.56 Million
16,992 Added 71.05%
40,907 $3.23 Million
Q4 2019

Feb 07, 2020
BUY
$78.51 - $87.4 $87,852 - $97,800
1,119 Added 4.91%
23,915 $2.08 Million
Q3 2019

Nov 01, 2019
SELL
$81.84 - $88.74 $69,727 - $75,606
-852 Reduced 3.6%
22,796 $1.91 Million
Q2 2019

Aug 09, 2019
SELL
$72.88 - $85.0 $149,258 - $174,080
-2,048 Reduced 7.97%
23,648 $1.99 Million
Q1 2019

May 09, 2019
SELL
$66.22 - $80.06 $24,435 - $29,542
-369 Reduced 1.42%
25,696 $2.05 Million
Q4 2018

Feb 11, 2019
SELL
$65.56 - $74.27 $15,734 - $17,824
-240 Reduced 0.91%
26,065 $1.89 Million
Q3 2018

Nov 02, 2018
SELL
$60.81 - $73.36 $86,046 - $103,804
-1,415 Reduced 5.1%
26,305 $1.93 Million
Q2 2018

Jul 27, 2018
SELL
$57.57 - $63.54 $109,037 - $120,344
-1,894 Reduced 6.4%
27,720 $1.69 Million
Q1 2018

May 11, 2018
SELL
$56.27 - $63.62 $142,531 - $161,149
-2,533 Reduced 7.88%
29,614 $1.77 Million
Q4 2017

Feb 09, 2018
SELL
$53.68 - $57.47 $73,219 - $78,389
-1,364 Reduced 4.07%
32,147 $1.84 Million
Q3 2017

Nov 13, 2017
SELL
$48.06 - $53.64 $240,828 - $268,790
-5,011 Reduced 13.01%
33,511 $1.79 Million
Q2 2017

Aug 10, 2017
BUY
N/A
38,522
38,522 $1.87 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email